SCLX
Scilex Holding Co
NASDAQ · Pharmaceuticals
$8.49
+0.63 (+8.02%)
Open$7.86
Previous Close$7.86
Day High$8.67
Day Low$7.82
52W High$40.06
52W Low$24.33
Volume—
Avg Volume347.6K
Market Cap72.09M
P/E Ratio23.07
EPS$1.48
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+353.8% upside
Current
$8.49
$8.49
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.62M | 16.86M | 18.16M |
| Net Income | 3.41M | 3.00M | 3.07M |
| Profit Margin | 20.5% | 17.8% | 16.9% |
| EBITDA | 6.17M | 6.50M | 7.12M |
| Free Cash Flow | 2.59M | 2.15M | 2.89M |
| Rev Growth | -3.0% | +5.1% | -1.1% |
| Debt/Equity | 0.22 | 0.30 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |